Work

Corrigendum to “Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow” [Bioorg. Med. Chem. Lett. 29 (2019) 2575–2580]

Year: 2020

Type: erratum

Source: Bioorganic & Medicinal Chemistry Letters

DOI: 10.1016/j.bmcl.2020.127363

Authors: Xavier Fradera, Joey L. Methot, Abdelghani Achab, Matthew Christopher, Michael D. Altman, Hua Zhou, Meredeth A. McGowan, Sam D. Kattar, Kevin Wilson, Yudith Garcia, Martin A. Augustin, Charles A. Lesburg, Sanjiv Shah, Peter Goldenblatt, Jason D. Katz

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

Open Access status: closed

OpenAlex ID: W3036387353

Cites:

Cited by: 1

Related to: 10